Evercore ISI Keeps Their Buy Rating on Shattuck Labs (STTK)
BTIG Sticks to Its Hold Rating for Shattuck Labs (STTK)
Shattuck Labs Analyst Ratings
Citigroup Maintains Buy on Shattuck Labs, Lowers Price Target to $9
Shattuck Labs Analyst Ratings
Shattuck Labs Analyst Ratings
HC Wainwright & Co. : The Shattuck Labs (STTK.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $28.00.
HC Wainwright & Co. Reiterates Buy on Shattuck Labs, Maintains $28 Price Target
TD Cowen Remains a Buy on Shattuck Labs (STTK)
Promising Clinical Trial Results Support a Buy Rating for Shattuck Labs
Shattuck Labs Analyst Ratings
Needham Reiterates Buy on Shattuck Labs, Maintains $12 Price Target
Buy Rating Affirmed: Shattuck Labs' Promising Clinical Developments in HR-MDS and AML Treatment
Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Acrivon Therapeutics, Inc. (ACRV)
Needham: Reiterates Shattuck Labs (STTK.US) rating and adjusted from buy to buy rating, target price is $12.00.
Buy Rating Affirmed for Shattuck Labs Ahead of Key Clinical Trial Updates on SL-172154
HC Wainwright & Co. Reiterates Buy on Shattuck Labs, Maintains $28 Price Target
Shattuck Labs Analyst Ratings
Shattuck Labs: Buy Rating Affirmed on Strong Q1 Financials and Promising Clinical Milestones
Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Verastem (VSTM)